Cargando…

Anti-Ro52 positivity is associated with progressive interstitial lung disease in systemic sclerosis—an exploratory study

BACKGROUND: Interstitial lung disease (ILD) is the most common cause of death in patients with systemic sclerosis (SSc). Prognostic biomarkers are needed to identify SSc-ILD patients at risk for progressive pulmonary fibrosis. This study investigates autoantibodies measured in bronchoalveolar lavage...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hamberg, Viggo, Sohrabian, Azita, Volkmann, Elizabeth R., Wildt, Marie, Löfdahl, Anna, Wuttge, Dirk M., Hesselstrand, Roger, Dellgren, Göran, Westergren-Thorsson, Gunilla, Rönnelid, Johan, Andréasson, Kristofer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476305/ https://www.ncbi.nlm.nih.gov/pubmed/37667402 http://dx.doi.org/10.1186/s13075-023-03141-4

Ejemplares similares

Absence of fibromodulin affects matrix composition, collagen deposition and cell turnover in healthy and fibrotic lung parenchyma
por: Rydell-Törmänen, Kristina, et al.
Publicado: (2014)

Pathological Insight into 5-HT(2B) Receptor Activation in Fibrosing Interstitial Lung Diseases
por: Löfdahl, Anna, et al.
Publicado: (2020)

CD105(+)CD90(+)CD13(+) identifies a clonogenic subset of adventitial lung fibroblasts
por: Kadefors, Måns, et al.
Publicado: (2021)

Pulmonary arterial hypertension in systemic sclerosis—when criteria and pathobiology differ
por: Andréasson, Kristofer, et al.
Publicado: (2019)

Distal Lung Microenvironment Triggers Release of Mediators Recognized as Potential Systemic Biomarkers for Idiopathic Pulmonary Fibrosis
por: Kalafatis, Dimitrios, et al.
Publicado: (2021)

Dipeptidyl peptidase 4 expression is not associated with an activated fibroblast phenotype in idiopathic pulmonary fibrosis
por: Kadefors, Måns, et al.
Publicado: (2022)

Alveolar epithelial cells are competent producers of interstitial extracellular matrix with disease relevant plasticity in a human in vitro 3D model
por: Rosmark, Oskar, et al.
Publicado: (2023)

Presentations and outcomes of interstitial lung disease and the anti-Ro52 autoantibody
por: Sclafani, A., et al.
Publicado: (2019)

Mycophenolate mofetil for systemic sclerosis: drug exposure exhibits considerable inter-individual variation—a prospective, observational study
por: Andréasson, Kristofer, et al.
Publicado: (2020)

A tunable physiomimetic stretch system evaluated with precision cut lung slices and recellularized human lung scaffolds
por: Rosmark, Oskar, et al.
Publicado: (2022)

Granulocyte‐augmented chemokine production induced by type II collagen containing immune complexes is mediated via TLR4 in rheumatoid arthritis patients
por: Manivel, Vivek Anand, et al.
Publicado: (2016)

Converging pathways in pulmonary fibrosis and Covid-19 - The fibrotic link to disease severity
por: Wigén, Jenny, et al.
Publicado: (2020)

Normal serum levels of immune complexes in postpolio patients
por: Melin, Eva, et al.
Publicado: (2014)

High frequency ultrasound of skin involvement in systemic sclerosis – a follow-up study
por: Hesselstrand, Roger, et al.
Publicado: (2015)

Impaired Differentiation of Chronic Obstructive Pulmonary Disease Bronchial Epithelial Cells Grown on Bronchial Scaffolds
por: Hedström, Ulf, et al.
Publicado: (2021)

Altered fibroblast proteoglycan production in COPD
por: Hallgren, Oskar, et al.
Publicado: (2010)

Anti-Ro52 Antibodies and Interstitial Lung Disease in Connective Tissue Diseases Excluding Scleroderma
por: Ferreira, João Pedro, et al.
Publicado: (2012)

Pulmonary fibrosis in vivo displays increased p21 expression reduced by 5-HT(2B) receptor antagonists in vitro – a potential pathway affecting proliferation
por: Löfdahl, Anna, et al.
Publicado: (2018)

Multiple Manifestations of Systemic Sclerosis Affect Walk Distance
por: Andréasson, Kristofer, et al.
Publicado: (2021)

Persistent elevation of fibrosis biomarker cartilage oligomeric matrix protein following hepatitis C virus eradication
por: Andréasson, Kristofer, et al.
Publicado: (2019)

Elevated fecal levels of the inflammatory biomarker calprotectin in early systemic sclerosis
por: Hamberg, Viggo, et al.
Publicado: (2022)

Clinical characteristics of idiopathic interstitial pneumonias with anti-Ro52/tripartite motif-containing 21 antibodies
por: Tahara, Masahiro, et al.
Publicado: (2022)

Highlights on Novel Technologies for the Detection of Antibodies to Ro60, Ro52, and SS-B
por: Infantino, M., et al.
Publicado: (2013)

Auto-antibody evaluation in idiopathic interstitial pneumonia and worse survival of patients with Ro52/TRIM21auto-antibody
por: Morita, Hiroko, et al.
Publicado: (2020)

Association of anti-Ro52 autoantibody with interstitial lung disease in autoimmune diseases: a systematic review and meta-analysis
por: Nayebirad, Sepehr, et al.
Publicado: (2023)

Matrisome Properties of Scaffolds Direct Fibroblasts in Idiopathic Pulmonary Fibrosis
por: Elowsson Rendin, Linda, et al.
Publicado: (2019)

Analysis of autoantibodies against Ro52/Ro60 in patients with suspected diagnosis of autoimmune systemic disease
por: Salvador, Iñaki, et al.
Publicado: (2012)

Anti-Ro60 Seropositivity Determines Anti-Ro52 Epitope Mapping in Patients With Systemic Sclerosis
por: Gkoutzourelas, Athanasios, et al.
Publicado: (2018)

Analysis of anti-Ro52 antibodies in sera of healthy subjects
por: Zimmermann, C, et al.
Publicado: (2001)

Harnessing the ECM Microenvironment to Ameliorate Mesenchymal Stromal Cell-Based Therapy in Chronic Lung Diseases
por: Elowsson Rendin, Linda, et al.
Publicado: (2021)

5‐HT (2B) receptor antagonists attenuate myofibroblast differentiation and subsequent fibrotic responses in vitro and in vivo
por: Löfdahl, Anna, et al.
Publicado: (2016)

Defective alterations in the collagen network to prostacyclin in COPD lung fibroblasts
por: Larsson-Callerfelt, Anna-Karin, et al.
Publicado: (2013)

Ciliated (FOXJ1(+)) Cells Display Reduced Ferritin Light Chain in the Airways of Idiopathic Pulmonary Fibrosis Patients
por: Wijk, Sofia C., et al.
Publicado: (2022)

Anti-Ro52/Anti-nuclear Matrix Protein 2 Positive Clinically Amyopathic Dermatomyositis Presented Only With Interstitial Lung Disease
por: Skrimizeas, Stratos, et al.
Publicado: (2023)

Mortality risk in patients with anti-MDA5 dermatomyositis is related to rapidly progressive interstitial lung disease and anti-Ro52 antibody
por: Wang, Huyan, et al.
Publicado: (2023)

Zinc finger domain of Ro60kD autoantigen is essential for binding of Ro52kD and autoantibodies
por: Routsias, JG, et al.
Publicado: (2003)

Diagnostic Utility of Separate Anti-Ro60 and Anti-Ro52/TRIM21 Antibody Detection in Autoimmune Diseases
por: Robbins, Ailsa, et al.
Publicado: (2019)

Activated MC(TC )mast cells infiltrate diseased lung areas in cystic fibrosis and idiopathic pulmonary fibrosis
por: Andersson, Cecilia K, et al.
Publicado: (2011)

Clinical significance of antibodies to Ro52/TRIM21 in systemic sclerosis
por: Hudson, Marie, et al.
Publicado: (2012)

TRIM21/Ro52 - Roles in Innate Immunity and Autoimmune Disease
por: Jones, Esther L., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_n23su09aq7kdl3ml7nbfcj0em0